Suppr超能文献

[巴奇-基什孔县教学医院乳腺癌患者的前哨淋巴结活检]

[Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital].

作者信息

Cserni Gábor, Rajtár Mária, Boross Gábor, Sinkó Mária, Svébis Mihály, Baltás Béla, Ambrózay Eva, Szúcs Miklós

机构信息

Bács-Kiskun Megyei Onkormányzat Kórháza, Szegedi Tudományegyetem Altalános Orvostudományi Kar Oktató Kórháza, Kecskemét, Patológiai osztály.

出版信息

Orv Hetil. 2002 Mar 3;143(9):437-46.

Abstract

INTRODUCTION

The optimal technique of sentinel node biopsy (SNB) is still debated.

AIMS

To compare two methods of SNB, describe the learning phase, the validation of the methods and the first results after implementing SNB as standard of care in selected breast cancer patients.

PATIENTS AND METHODS

SNB with peritumoral or intratumoral injection of Patent blue dye only was performed in 129 clinically T1-T2 and N0 breast cancers in 127 patients (Group A); it was later replaced by combined dye and radiocolloid-guided SNB preceded by lymphoscintigraphy in 72 breast cancer patients (Group B). All patients underwent completion axillary dissection. Group C, to date, comprises 50 patients, in whom axillary dissection was performed on the basis of the SNB. Intraoperative imprint cytology was performed, and whenever positive, the axillary dissection was completed in the same step, whereas in cases of negative cytology findings but positive final histology, the dissection was done as a second operation. Histopathological assessment of SNs involved step sectioning and immunohistochemistry.

RESULTS

Means of 1.4 and 1.3 SNs were identified in Groups A and B, respectively. The mean number of non-SNs for the whole series was 14.7 (range 5-42). The first 53 cases of lymphatic mapping with patent blue dye comprised the institutional learning period, during which the identification rate of at least 1 SN in 30 consecutive attempts reached 90%. The identification rate for the subsequent 76 Group A patients was 92%. The accuracy of SNB for overall axillary nodal status prediction and the false-negative rate for Group A patients (after exclusion of the learning-phase cases) were 93% and 10%, respectively. All 72 Group B cases had at least 1 SN identified, and only 1 false-negative case occurred in this group, i.e. the accuracy and false-negative rate were 99% and 3%, respectively. The identification rate in Group C was 98%; axillary dissection could be avoided in 25 patients, it was performed at the same time as the SNB in 15 and as a second operation in 10. Till now, no axillary recurrence was detected in Group C patients, although the follow-up period is short for the moment.

CONCLUSIONS

The dye only and the radioguided SNB methods are complementary, their combination improves the performance, and can be the basis of performing axillary dissection on the basis of SNB results. After the technique of SNB has been validated in a given institution, it can become standard of care in a well selected group of patients, but requires a close follow up.

摘要

引言

前哨淋巴结活检(SNB)的最佳技术仍存在争议。

目的

比较两种SNB方法,描述学习阶段、方法验证以及在选定的乳腺癌患者中将SNB作为标准治疗方法后的初步结果。

患者与方法

对127例患者的129例临床T1 - T2且N0期乳腺癌仅采用肿瘤周围或瘤内注射专利蓝染料进行SNB(A组);随后在72例乳腺癌患者中采用联合染料和放射性胶体引导的SNB并先行淋巴闪烁显像术取代了前者(B组)。所有患者均接受了腋窝淋巴结清扫术。C组目前包括50例患者,其腋窝淋巴结清扫术是基于SNB结果进行的。术中进行印片细胞学检查,若结果为阳性,则在同一步骤完成腋窝淋巴结清扫;若细胞学检查结果为阴性但最终组织学检查为阳性,则作为第二次手术进行清扫。对前哨淋巴结进行组织病理学评估包括连续切片和免疫组织化学。

结果

A组和B组分别平均发现1.4个和1.3个前哨淋巴结。整个系列中非前哨淋巴结的平均数量为14.7个(范围5 - 42个)。最初的53例使用专利蓝染料进行淋巴绘图的病例构成了机构学习期,在此期间,连续30次尝试中至少识别出1个前哨淋巴结的识别率达到90%。随后76例A组患者的识别率为92%。A组患者(排除学习期病例后)前哨淋巴结活检对总体腋窝淋巴结状态预测的准确率和假阴性率分别为93%和10%。B组的所有72例病例均至少识别出1个前哨淋巴结,该组仅出现1例假阴性病例,即准确率和假阴性率分别为99%和3%。C组的识别率为98%;25例患者可避免腋窝淋巴结清扫术,15例与前哨淋巴结活检同时进行,10例作为第二次手术进行。目前C组患者虽随访期较短,但尚未检测到腋窝复发。

结论

单纯染料法和放射性引导前哨淋巴结活检方法具有互补性,两者结合可提高性能,并可作为基于前哨淋巴结活检结果进行腋窝淋巴结清扫的基础。在前哨淋巴结活检技术在特定机构得到验证后,它可成为精心挑选的一组患者的标准治疗方法,但需要密切随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验